Zealand Pharma A/s Stock
€56.30
Your prediction
Zealand Pharma A/s Stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
Cons
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | -4.040% | -8.900% | -16.765% | -42.316% | -12.004% | 106.833% | - |
| Saniona AB | 1.670% | 0.725% | -0.613% | 220.264% | 1.356% | 616.022% | -7.867% |
| Actinium Pharmaceuticals Inc. | 2.860% | 2.852% | -2.936% | -7.321% | -1.408% | -86.408% | -82.370% |
| NanoViricides Inc. | 0.990% | 0.000% | -9.735% | -22.727% | 9.677% | -17.542% | -61.654% |
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big


